Pasireotide Extended-Release Injection and Ritonavir Tablets
Determining the interaction of Pasireotide Extended-Release Injection and Ritonavir Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: ritonavir
Brand name: Norvir, Norvir Soft Gelatin
Synonyms: Ritonavir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Rituxan
- Pasireotide Extended-Release Injection-Rituxan Hycela
- Pasireotide Extended-Release Injection-Rituximab
- Pasireotide Extended-Release Injection-Rituximab and Hyaluronidase
- Pasireotide Extended-Release Injection-Rituximab and hyaluronidase human, recombinant Subcutaneous
- Pasireotide Extended-Release Injection-Rituximab Intravenous
- Ritonavir Tablets-Pasireotide Injection
- Ritonavir Tablets-Pasireotide Subcutaneous
- Ritonavir Tablets-Patanase
- Ritonavir Tablets-Patiromer
- Ritonavir Tablets-Patiromer Sorbitex Calcium
- Ritonavir Tablets-Pavacot